Cargando…
Liposome based drug delivery as a potential treatment option for Alzheimer's disease
Alzheimer’s disease is a neurodegenerative condition leading to atrophy of the brain and robbing nearly 5.8 million individuals in the United States age 65 and older of their cognitive functions. Alzheimer’s disease is associated with dementia and a progressive decline in memory, thinking, and socia...
Autores principales: | Hernandez, Carely, Shukla, Surabhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643057/ https://www.ncbi.nlm.nih.gov/pubmed/34782553 http://dx.doi.org/10.4103/1673-5374.327328 |
Ejemplares similares
-
Liposome delivery systems for the treatment of Alzheimer’s disease
por: Ross, Callum, et al.
Publicado: (2018) -
Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
por: Cho, HaEun, et al.
Publicado: (2020) -
Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment
por: Nikolova, Maria P., et al.
Publicado: (2022) -
Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery
por: Lamichhane, Narottam, et al.
Publicado: (2018) -
Perspective on the Application of Erythrocyte Liposome-Based Drug Delivery for Infectious Diseases
por: Krivić, Hannah, et al.
Publicado: (2022)